Barinthus Biotherapeutics
BRNS
$2.35
Share price
-3.29%
Change (1 day)
-0.84%
Change (1 year)
Categories
Revenue for Barinthus Biotherapeutics (BRNS)
Revenue in 2023 (TTM): $0.8 M
According to Barinthus Biotherapeutics's latest financial reports the company's current revenue (TTM
) is $0.8 M.
In 2022 the company made a revenue of $44.7 M an increase over the years 2021 revenue that were of $0.26 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Barinthus Biotherapeutics from 2020 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.8 M | -98.21% |
| 2022 | $44.7 M | 16580.22% |
| 2021 | $0.26 M | -94.44% |
| 2020 | $4.82 M |